AYRTN - Ayrton Drugs Manufacturing Co.
Ayrton Drugs is a pharmaceutical company that manufactures high quality medicines at affordable prices. It also deals with exportation and importation of drugs. The company was incorporated on 24th September, 1965 and was then issued with a certificate to commence Ayrton Drugs Manufacturing on 21st October, 1965. The company began in a small plant in Kokomlemle with a few tablet making machines and 10 employees. It moved to its current location on the Abeka Road, Tesano in 1969. It currently employs about 348 people.
NOTE: Shares of Ayrton Drugs Manufacturing Co. have been delisted from the Ghana Stock Exchange (GSE) since close of trading on Tuesday, January 14, 2020. Ayrton Drugs Manufacturing was traded on the GSE under the ticker symbol “AYRTN”. Ayrton Drugs Manufacturing Co. had a market capitalization of GHS 17.2 million.
|Last Trading Results|
|Day’s Low Price|
|Day’s High Price|
|Number of Deals||0|
|Growth & Valuation|
|Earnings Per Share||-0.0058|
|Dividend Per Share||0.00|
AYRTN Stock Market Performance
The current share price of Ayrton Drugs Manufacturing Co. (AYRTN) is GHS 0.08. AYRTN closed its last trading day (Tuesday, December 24, 2019) at 0.08 GHS per share on the Ghana Stock Exchange (GSE).
Ayrton Drugs Manufacturing Co. is the 21st most traded stock on the Ghana Stock Exchange over the past three months (Oct 8, 2019 - Jan 14, 2020). AYRTN has traded a total volume of 2,000 shares valued at GHS 160 over the period. A volume high of 2,000 was achieved on December 24th for the same period. The table below details the last 10 trading days of activity of Ayrton Drugs Manufacturing on the Ghana Stock Exchange.
Profile of Ayrton Drugs Manufacturing Company Ltd.
Ayrton Drugs Manufacturing Company Ltd. operates in the Health Care sector.
Factsheet of Ayrton Drugs Manufacturing Company Ltd.
- Health Care
- P. O. Box 2149, Accra
AYRTN Industrial Market Competitors
Ayrton Drugs Manufacturing Company Ltd., issuers of the AYRTN stock on the Ghana Stock Exchange, have two market competitors who are also engaged in the Health Care sector. The table below presents an overview of their market standing.
|DASPHARMA||Dannex Ayrton Starwin Plc||33.9M||0.40|
|IIL||Intravenous Infusions Limited||10.4M||0.04||-20%|